MonoSolRx cements its drug film manufacturing position

MonoSolRx has received notice of allowance for an Irish patent entitled: 'Method of Testing Uniformity in a Film Manufacturing Process.'

P. Scott Bening, president and ceo, MonoSolRx, said: 'by seeking protection in Ireland, which is such an important base for the manufacture of pharmaceuticals, we are making an important step in the company's IP strategy.'

Richard C. Fuisz M.D., inventor of the patent in Ireland, said: 'this is quite a strong patent with broad basic claims on important aspects of uniform drug film manufacture. It represents an opportunity for exclusive Irish manufacture, and complements our existing IP portfolio.'

MonoSolRx, headquartered in Portage, Indiana, is a leading drug delivery company that uses film as a fast-dissolve oral drug delivery platform. Its FDTAB film oral dosage form looks like a postage stamp and dissolves readily on the tongue to deliver drugs to a patient, replacing the use of conventional tablets and capsules. The company previously acquired all of the assets of Kosmos Pharma, including its extensive oral film intellectual property portfolio.

Company

T +1 219 762 3165 F +1 219 764 4785 psbening@monosol.com